↓ Skip to main content

The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data

Overview of attention for article published in BMC Cancer, October 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
8 tweeters

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data
Published in
BMC Cancer, October 2019
DOI 10.1186/s12885-019-6209-9
Pubmed ID
Authors

Pablo Fernández-Navarro, Pilar López-Nieva, Elena Piñeiro-Yañez, Gonzalo Carreño-Tarragona, Joaquín Martinez-López, Raúl Sánchez Pérez, Ángel Aroca, Fátima Al-Shahrour, María Ángeles Cobos-Fernández, José Fernández-Piqueras

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 20%
Student > Postgraduate 2 13%
Student > Ph. D. Student 2 13%
Researcher 2 13%
Student > Doctoral Student 1 7%
Other 3 20%
Unknown 2 13%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 27%
Medicine and Dentistry 2 13%
Computer Science 2 13%
Agricultural and Biological Sciences 1 7%
Nursing and Health Professions 1 7%
Other 2 13%
Unknown 3 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 February 2020.
All research outputs
#4,474,350
of 15,720,497 outputs
Outputs from BMC Cancer
#1,139
of 5,863 outputs
Outputs of similar age
#116,863
of 327,863 outputs
Outputs of similar age from BMC Cancer
#145
of 724 outputs
Altmetric has tracked 15,720,497 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 5,863 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,863 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 724 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.